Molecular and Cellular Biochemistry · 2011 · 18 citations · 36 references
ArchitectureArchitectural EngineeringHistoric PreservationArchitectural ConservationBuilding MaterialsConservation ScienceBrick ConservationBrick UnitsConservation MaterialsMaterial Conservation PrinciplesMaterial PerformanceMortar ConservationBrick Material CharacterizationConservation Materials TestingConservation MortarsHistoric Preservation ImpactLime Mortar ConservationLime MortarsLime-based MortarsPozzolanic Reactions
Lymphoma is the most common malignant tumor arising from immune system. Recently, DNA polymerase epsilon subunit 2 (POLE2) was identified to be a tumor promotor in a variety of malignant tumors. However, the biological role of POLE2 in lymphoma is still largely unclear. In our present study, the expression patterns of POLE2 in lymphoma tissues were identified by immunohistochemistry (IHC) staining of human tissue microarray. Cell viability was determined by CCK-8 assay. Cell apoptosis and cycle distribution were evaluated by Annexin V and PI staining, respectively. Cell migration was analyzed by transwell assay. Tumor growth in vivo was observed by a xenograft model of mice. The potential signaling was explored by human phospho-kinase array and immunoblotting. POLE2 was significantly upregulated in human lymphoma tissues and cells. POLE2 knockdown attenuated the proliferation, migration capabilities of lymphoma cells, as well as induced cell apoptosis and cycle arrest. Moreover, POLE2 depletion impaired the tumor growth in mice. Furthermore, POLE2 knockdown apparently inhibited the activation of β-Catenin and downregulated the expression of Wnt/β-Catenin signaling-related proteins. POLE2 knockdown suppressed the proliferation and migration of lymphoma cells by inhibiting Wnt/β-Catenin signaling pathway. POLE2 may serve as a novel therapeutic target for lymphoma.
36
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2019 · 21K citations · Full text
Restoration of p53 function leads to tumour regression in vivo
Andrea Ventura, David G. Kirsch, Margaret E. McLaughlin et al. · Nature · 2007 · 1.8K citations
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
Michael Crump, Sattva S. Neelapu, Umar Farooq et al. · Blood · 2017 · 1.7K citations · Full text
Medicine, Hematology, Oncology +10
ASTM Special Technical Publication
Simo‐Pekka Hannula, J. Wanagel, Che Yu Li · 1986 · 1.2K citations
Anas Younes, Laurie H. Sehn, Peter Johnson et al. · Journal of Clinical Oncology · 2019 · 616 citations · Full text
Medicine, Oncology, Pharmacotherapy +12